KRAS and neoplasm: Notably, despite no statistical significance, loss of Zbtb11 still showed a tendency of reduced or slowed formation of the primary lung tumors induced by aberrant Kras and Lkb1 (Fig. 8d), supporting ZBTB11 as an oncoprotein that may contribute to tumor initiation, to some extent, in vivo.